Research Article

Development of Topical Niosomal Gel of Benzoyl Peroxide

Table 6

Table contains data of drug leakage study at RT and refrigerated temperature.

Time in weeksPercentage drug retained (±SD)
Niosomal suspensionNiosomal gel of Carbopol
4°C (NS)RT (NS)4°C (NG)RT (NG)

198.90 (±3.74)89.11 (±3.33)99.89 (±3.26)94.20 (±2.72)
297.30 (±3.67)78.83 (±3.41)99.22 (±2.11)87.09 (±3.92)
395.89 (±3.16)68.22 (±2.98)98.73 (±3.94)81.82 (±3.16)
493.55 (±2.71)61.19 (±2.86)98.32 (±4.02)76.90 (±3.57)
589.48 (±1.76)54.40 (±1.99)98.02 (±3.65)72.10 (±1.78)
686.88 (±1.24)46.21 (±1.32)97.77 (±2.83)68.89 (±2.78)
782.77 (±2.43)39.11 (±0.74)97.56 (±1.98)65.11 (±2.67)
878.92 (±0.74)33.38 (±0.43)97.38 (±2.87)61.08 (±1.96)
975.45 (±1.17)28.39 (±1.15)97.22 (±3.49)58.12 (±1.14)
1073.29 (±1.87)23.45 (±1.07)97.07 (±2.67)56.23 (±1.08)
1170.67 (±2.87)20.04 (±0.56)96.97 (±1.10)53.55 (±1.17)
1265.89 (±1.65)17.12 (±0.48)96.85 (±2.26)51.07 (±2.22)

𝑛 = 3 ; RT: room temperature (25 ± 2°C); NS: niosomal suspension; NG: niosomal gel.